journal article·2014-08

A novel bubble-forming material for preparing hydrophobic-agent-loaded bubbles with theranostic functionality

Pei-Sin Yang, Fu-I Tung, Hsiao-Ping Chen, Tse-Ying Liu, Yi-Ying Lin

Acta Biomaterialia· Volume 10· Issue 8
Publisher page

Abstract

In the present study, a new bubble-forming material (carboxymethyl hexanoyl chitosan, CHC), together with superparamagnetic iron oxide (SPIO) nanoparticles, was employed to prepare image-guided bubbles for efficiently encapsulating and delivering hydrophobic agents to kill tumor cells. The results showed that CHC could be used for preparing not only micronized bubbles (CHC/SPIO MBs) to exhibit ultrasound imaging functionality but also nanosized bubbles (CHC/SPIO NBs) to exhibit magnetic resonance T2 image contrast. It was found that the amounts of SPIO nanoparticles and hexane during preparation process were the key factors to obtaining CHC/SPIO NBs. Most importantly, under in vitro cell culture conditions with the same amount of camptothecin (CPT) and therapeutic sonication, CPT-loaded CHC/SPIO NBs demonstrated more significant transcellular delivery and cytotoxicity than free CPT. Subsequently, an intratumoral injection was proposed for the in vivo administration of hydrophobic-agent-loaded CHC/SPIO NBs. After injection, the distribution of a hydrophobic dye (DiR, an agent with near-infrared (NIR) fluorescence used as a model drug) released from the CHC/SPIO NBs was tracked by an NIR imaging technique. A significant tumor-specific accumulation was observed in the mouse that received the DiR-loaded CHC/SPIO NBs; the same was not observed in the mouse that received the free dye (without incorporating with CHC/SPIO NBs). It is expected, in the future, both the dose of the therapeutic agent administered and its side effects can be significantly lowered by using novel CHC/SPIO NBs together with local delivery (intratumoral injection), targeted imaging and enhanced cellular uptake of the drug.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Ultrasound and Hyperthermia Applications · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (37)

Show source-provided references
1. Advanced methodologies to formulate nanotheragnostic agents for combined drug delivery and imaging10.1517/17425247.2012.634794 ↗
2. Novel ultrasound-triggered drug vehicle with multimodal imaging functionality10.1016/j.actbio.2012.11.023 ↗
3. Image-guided nanosystems for targeted delivery in cancer therapy10.2174/092986712800784685 ↗
4. Image guided therapy: the advent of theranostic agents10.1016/j.jconrel.2012.05.028 ↗
5. Noninvasive monitoring of local drug release using X-ray computed tomography: optimization and in vitro/in vivo validation10.1002/jps.10295 ↗
6. Multifunctional alginate microspheres for biosensing, drug delivery and magnetic resonance imaging10.1016/j.actbio.2011.06.053 ↗
7. Fluorescence nanoparticles “quantum dots” as drug delivery system and their toxicity: a review10.3109/1061186X.2010.526227 ↗
8. Ultrasound triggered image-guided drug delivery10.1016/j.ejrad.2009.01.051 ↗
9. Nanomaterials for photo-based diagnostic and therapeutic applications10.7150/thno.5327 ↗
10. Theranostics: combining imaging and therapy10.1021/bc200151q ↗
11. Nanotechnologies for Alzheimer’s disease: diagnosis, therapy, and safety issues10.1016/j.nano.2011.03.008 ↗
12. Intravascular targets for molecular contrast-enhanced ultrasound imaging10.3390/ijms13066679 ↗
13. Intracellular hyperthermia: nanobubbles and their biomedical applications10.3109/02656730903061617 ↗
14. Nanobubbles for enhanced ultrasound imaging of tumors
15. Evaluation of antitumor effects following tumor necrosis factor-alpha gene delivery using nanobubbles and ultrasound10.1111/j.1349-7006.2011.02056.x ↗
16. Preparation and characterization of dextran nanobubbles for oxygen delivery10.1016/j.ijpharm.2009.07.010 ↗
17. Preparation of nanobubbles for ultrasound imaging and intracellular drug delivery10.1016/j.ijpharm.2009.09.027 ↗
18. Synthesizing and binding dual-mode poly (lactic-co-glycolic acid) (PLGA) nanobubbles for cancer targeting and imaging10.1016/j.biomaterials.2009.11.052 ↗
19. The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging10.1088/0957-4484/21/14/145607 ↗
20. Response of contrast agents to ultrasound10.1016/j.addr.2008.03.011 ↗
21. Polymeric theranostics: using polymer-based systems for simultaneous imaging and therapy10.1039/c3tb20191k ↗
22. Synthesis and characterization of amphiphatic carboxymethyl-hexanoyl chitosan hydrogel: water-retention ability and drug encapsulation10.1021/la061471n ↗
23. Novel pH-sensitive chitosan-based hydrogel for encapsulating poorly water-soluble drugs10.1016/j.actbio.2009.10.010 ↗
24. Corneal repair by human corneal keratocyte-reprogrammed iPSCs and amphiphatic carboxymethyl-hexanoyl chitosan hydrogel10.1016/j.biomaterials.2012.07.029 ↗
25. Molecular-functional imaging of cancer: to image and imagine10.1016/j.molmed.2007.05.002 ↗
26. Microbubbles loaded with nanoparticles: a route to multiple imaging modalities10.1021/nn102248g ↗
27. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging10.1016/j.biomaterials.2009.03.051 ↗
28. Magnetic and acoustically active lipospheres for magnetically targeted nucleic acid delivery10.1002/adfm.200902388 ↗
29. Image-guided, targeted and triggered drug delivery to tumors using polymer-based microbubbles10.1016/j.jconrel.2012.05.007 ↗
30. Monodisperse MFe2O4 (M=Fe Co, Mn) nanoparticles10.1021/ja0380852 ↗
31. Read-Hill · 1991
32. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery10.1016/j.jconrel.2006.05.018 ↗
33. Progress in functionalization of magnetic nanoparticles for applications in biomedicine10.1088/0022-3727/42/22/224003 ↗
34. Classification and basic properties of contrast agents for magnetic resonance imaging10.1002/cmmi.265 ↗
35. Effect of 90Y-microspheres on liver tumors: comparison of intratumoral injection method and intra-arterial injection method
36. Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection10.1016/j.ijpharm.2006.02.039 ↗
37. Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors10.1200/JCO.2004.04.059 ↗